Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 6/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.43 |
| ▸ | NPC1 | O15118 | 4/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 2/20 | 0.38 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | LDHA | P00338 | 1/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1432390 | 0.87 | ALDH1A1 (0.38) | ALDH1A1HPGDTSHRRAB9ASMN1; SMN2 | |
| SCHEMBL9199229 | 0.79 | ALDH1A1 (0.57) | ALDH1A1HPGDTSHRRAB9ANPC1 | |
| SCHEMBL9197824 | 0.79 | ALDH1A1 (0.57) | ALDH1A1HPGDTSHRSMN1; SMN2NPC1 | |
| SCHEMBL286332 | 0.79 | ALDH1A1 (0.63) | ALDH1A1HPGDTSHRRAB9ASMN1; SMN2 | |
| SCHEMBL2216614 | 0.79 | SMN1; SMN2 (0.40) | ALDH1A1HPGDTSHRRAB9ASMN1; SMN2 | |
| SCHEMBL9204332 | 0.78 | ALDH1A1 (0.41) | ALDH1A1HPGDTSHRRAB9ASMN1; SMN2 | |
| SCHEMBL9198002 | 0.78 | ALDH1A1 (0.44) | ALDH1A1HPGDRAB9ASMN1; SMN2NPC1 | |
| Hydrochloric Acid SCHEMBL9528992 | 0.77 | ALDH1A1 (0.61) | ALDH1A1HPGDTSHRRAB9ASMN1; SMN2 | |
| SCHEMBL28211661 | 0.77 | ALDH1A1 (0.45) | ALDH1A1HPGDTSHRRAB9ASMN1; SMN2 | |
| SCHEMBL6003366 | 0.76 | SMN1; SMN2 (0.41) | ALDH1A1HPGDTSHRRAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735426-A1 | HETEROAROMATIC DHODH INHIBITORS | Immunic AG (DE) | 2026-05-06 | — | — | EP | disclosed |
| WO-2025003402-A1 | HETEROAROMATIC DHODH INHIBITORS | IMMUNIC AG (DE) | 2025-01-02 | — | — | WO | disclosed |
| EP-2569375-B1 | MODIFIED PIGMENTS | CABOT CORP (US) | 2017-11-22 | — | — | EP | disclosed |
| US-8771411-B2 | Modified pigments | CABOT CORPORATION (US) | 2014-07-08 | — | — | US | disclosed |
| WO-2010013222-A1 | PYRROLE CARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS | RANBAXY LABORATORIES LIMITED (IN) | 2010-02-04 | — | — | WO | disclosed |
| US-20080214533-A1 | Cyclic Iminocarbamates And Their Use | BAYER HEALTHCARE AG (DE) | 2008-09-04 | — | — | US | disclosed |
| EP-1819701-A1 | CYCLIC IMINOCARBAMATES AND USE THEREOF | Bayer HealthCare AG (DE) | 2007-08-22 | — | — | EP | disclosed |
| WO-2006058630-A1 | CYCLIC IMINOCARBAMATES AND USE THEREOF | BAYER HEALTHCARE AG (DE) | 2006-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214533-A1 | Cyclic Iminocarbamates And Their Use | F2, UQCRB, F12 | ALDH1A1 348/4885HPGD 593/4885TSHR 1635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.